I Clinica Medica, Atherothrombosis Center, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom.
I Clinica Medica, Atherothrombosis Center, Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
Int J Cardiol. 2018 Mar 15;255:69-73. doi: 10.1016/j.ijcard.2017.12.076. Epub 2017 Dec 24.
To investigate the impact of concomitant asymptomatic peripheral artery disease (PAD) and pre-existing coronary artery disease (CAD) on cardiovascular events (CVEs) in atrial fibrillation (AF) patients.
Prospective multicenter study including 1138 anticoagulated AF patients. PAD was diagnosed by can ankle-brachial index (ABI)≤0.9, and CAD as a documented myocardial infarction (MI) or cardiac revascularization. The cohort was divided into 4 groups: group 0 (n=717) with no previous CAD and ABI >0.9; group 1 (n=168) no previous CAD and ABI≤0.9; group 2 (n=183) previous CAD and ABI >0.9: and group 3 (n=70) previous CAD and ABI≤0.9. The primary endpoint was a composite of CVEs.
Mean age was 72.6years and 41.3% were female. History of CAD was present in 253 (22.2%) patients, and 238 (20.9%) had an ABI≤0.9. Patients with previous CAD were more likely to have a low ABI compared to those without (OR:1.6, 95%CI 1.2-2.3, P=0.003). Median follow-up was 35.9months (IQR 19.2-57.2, 3819 patient-years), and 145 CVEs were recorded (3.8%/year 95%CI 3.2-4.5). Survival analysis showed a progressive increase in the rate of CVEs in the four groups (log-rank test P<0.001). Multivariable Cox regression analysis showed that as compared to group 0, group 1 (HR:1.8, 95%CI 1.1-2.9, P=0.01), group 2 (HR:2.2, 95%CI 1.4-3.4, P=0.001) and group 3 (HR:2.4, 95%CI 1.4-4.4, P=0.003) were associated with progressive greater risk of CVEs.
Patients with concomitant CAD and asymptomatic PAD are at high risk of CVEs, with a progressive risk with vascular disease burden where PAD was associated with CAD.
本研究旨在探讨无症状外周动脉疾病(PAD)合并并存的冠状动脉疾病(CAD)对心房颤动(AF)患者心血管事件(CVE)的影响。
这是一项前瞻性多中心研究,共纳入 1138 例接受抗凝治疗的 AF 患者。通过踝臂指数(ABI)≤0.9 诊断 PAD,通过已确诊的心肌梗死(MI)或心脏血运重建诊断 CAD。该队列分为 4 组:组 0(n=717)无既往 CAD 和 ABI>0.9;组 1(n=168)无既往 CAD 和 ABI≤0.9;组 2(n=183)既往 CAD 和 ABI>0.9;组 3(n=70)既往 CAD 和 ABI≤0.9。主要终点是 CVE 的复合结局。
平均年龄为 72.6 岁,41.3%为女性。253 例(22.2%)患者有 CAD 病史,238 例(20.9%)ABI≤0.9。与无 CAD 病史的患者相比,既往有 CAD 病史的患者更可能有较低的 ABI(比值比:1.6,95%CI 1.2-2.3,P=0.003)。中位随访时间为 35.9 个月(IQR 19.2-57.2,3819 患者年),记录到 145 例 CVE(3.8%/年,95%CI 3.2-4.5)。生存分析显示,四组之间 CVE 的发生率呈逐渐增加趋势(对数秩检验 P<0.001)。多变量 Cox 回归分析显示,与组 0 相比,组 1(HR:1.8,95%CI 1.1-2.9,P=0.01)、组 2(HR:2.2,95%CI 1.4-3.4,P=0.001)和组 3(HR:2.4,95%CI 1.4-4.4,P=0.003)与 CVE 的风险逐渐增加相关。
合并 CAD 和无症状 PAD 的患者发生 CVE 的风险较高,随着血管疾病负担的增加,PAD 与 CAD 相关,风险也逐渐增加。